Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer

S. Haricharan, S. M. Hein, J. Dong, M. J. Toneff, O. H. Aina, P. H. Rao, Robert Cardiff, Y. Li

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about the cellular origin of PABCs or the mechanisms by which PABCs are initiated. Using the RCAS retrovirus to deliver the ErbB2 oncogene into the mammary epithelium of our previously reported MMTV-tva transgenic mice, we detected high-grade, poorly differentiated, stroma-rich and ER-negative tumors during pregnancy and lactation. These high-grade and stroma-rich tumors were less frequent in involuted mice or in age-matched nulliparous mice. More importantly, by generating a WAP-tva transgenic line for expression of ErbB2 selectively in WAP+ mammary alveolar cells, we found that tumors had similar morphological phenotypes (high grade, poorly differentiated, stroma-rich and ER-negative), irrespective of the time since pregnancy and even in the absence of pregnancy. These data suggest that PABCs arise preferentially from an alveolar cell population that expands during pregnancy and lactation. This somatic mouse model may also be useful for preclinical testing of new prophylactic and therapeutic strategies against PABC.

Original languageEnglish (US)
Pages (from-to)5729-5739
Number of pages11
JournalOncogene
Volume33
Issue number50
DOIs
StatePublished - Dec 11 2014

Fingerprint

Alveolar Epithelial Cells
Breast Neoplasms
Phenotype
Pregnancy
Estrogen Receptors
Lactation
Breast
Neoplasms
Progesterone Receptors
Retroviridae
Oncogenes
Connective Tissue
Transgenic Mice
Epithelium
Parturition

Keywords

  • alveolar cells
  • breast cancer
  • PABC
  • pregnancy

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Haricharan, S., Hein, S. M., Dong, J., Toneff, M. J., Aina, O. H., Rao, P. H., ... Li, Y. (2014). Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. Oncogene, 33(50), 5729-5739. https://doi.org/10.1038/onc.2013.521

Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. / Haricharan, S.; Hein, S. M.; Dong, J.; Toneff, M. J.; Aina, O. H.; Rao, P. H.; Cardiff, Robert; Li, Y.

In: Oncogene, Vol. 33, No. 50, 11.12.2014, p. 5729-5739.

Research output: Contribution to journalArticle

Haricharan, S, Hein, SM, Dong, J, Toneff, MJ, Aina, OH, Rao, PH, Cardiff, R & Li, Y 2014, 'Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer', Oncogene, vol. 33, no. 50, pp. 5729-5739. https://doi.org/10.1038/onc.2013.521
Haricharan, S. ; Hein, S. M. ; Dong, J. ; Toneff, M. J. ; Aina, O. H. ; Rao, P. H. ; Cardiff, Robert ; Li, Y. / Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer. In: Oncogene. 2014 ; Vol. 33, No. 50. pp. 5729-5739.
@article{ccca4b09c7964eb988efad0de4f0898a,
title = "Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer",
abstract = "Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about the cellular origin of PABCs or the mechanisms by which PABCs are initiated. Using the RCAS retrovirus to deliver the ErbB2 oncogene into the mammary epithelium of our previously reported MMTV-tva transgenic mice, we detected high-grade, poorly differentiated, stroma-rich and ER-negative tumors during pregnancy and lactation. These high-grade and stroma-rich tumors were less frequent in involuted mice or in age-matched nulliparous mice. More importantly, by generating a WAP-tva transgenic line for expression of ErbB2 selectively in WAP+ mammary alveolar cells, we found that tumors had similar morphological phenotypes (high grade, poorly differentiated, stroma-rich and ER-negative), irrespective of the time since pregnancy and even in the absence of pregnancy. These data suggest that PABCs arise preferentially from an alveolar cell population that expands during pregnancy and lactation. This somatic mouse model may also be useful for preclinical testing of new prophylactic and therapeutic strategies against PABC.",
keywords = "alveolar cells, breast cancer, PABC, pregnancy",
author = "S. Haricharan and Hein, {S. M.} and J. Dong and Toneff, {M. J.} and Aina, {O. H.} and Rao, {P. H.} and Robert Cardiff and Y. Li",
year = "2014",
month = "12",
day = "11",
doi = "10.1038/onc.2013.521",
language = "English (US)",
volume = "33",
pages = "5729--5739",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "50",

}

TY - JOUR

T1 - Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer

AU - Haricharan, S.

AU - Hein, S. M.

AU - Dong, J.

AU - Toneff, M. J.

AU - Aina, O. H.

AU - Rao, P. H.

AU - Cardiff, Robert

AU - Li, Y.

PY - 2014/12/11

Y1 - 2014/12/11

N2 - Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about the cellular origin of PABCs or the mechanisms by which PABCs are initiated. Using the RCAS retrovirus to deliver the ErbB2 oncogene into the mammary epithelium of our previously reported MMTV-tva transgenic mice, we detected high-grade, poorly differentiated, stroma-rich and ER-negative tumors during pregnancy and lactation. These high-grade and stroma-rich tumors were less frequent in involuted mice or in age-matched nulliparous mice. More importantly, by generating a WAP-tva transgenic line for expression of ErbB2 selectively in WAP+ mammary alveolar cells, we found that tumors had similar morphological phenotypes (high grade, poorly differentiated, stroma-rich and ER-negative), irrespective of the time since pregnancy and even in the absence of pregnancy. These data suggest that PABCs arise preferentially from an alveolar cell population that expands during pregnancy and lactation. This somatic mouse model may also be useful for preclinical testing of new prophylactic and therapeutic strategies against PABC.

AB - Pregnancy-associated breast cancers (PABCs) are tumors diagnosed during pregnancy or up to 5 years following parturition, and are usually high-grade, connective tissue-rich, and estrogen receptor (ER)/progesterone receptor-negative. Little is known about the cellular origin of PABCs or the mechanisms by which PABCs are initiated. Using the RCAS retrovirus to deliver the ErbB2 oncogene into the mammary epithelium of our previously reported MMTV-tva transgenic mice, we detected high-grade, poorly differentiated, stroma-rich and ER-negative tumors during pregnancy and lactation. These high-grade and stroma-rich tumors were less frequent in involuted mice or in age-matched nulliparous mice. More importantly, by generating a WAP-tva transgenic line for expression of ErbB2 selectively in WAP+ mammary alveolar cells, we found that tumors had similar morphological phenotypes (high grade, poorly differentiated, stroma-rich and ER-negative), irrespective of the time since pregnancy and even in the absence of pregnancy. These data suggest that PABCs arise preferentially from an alveolar cell population that expands during pregnancy and lactation. This somatic mouse model may also be useful for preclinical testing of new prophylactic and therapeutic strategies against PABC.

KW - alveolar cells

KW - breast cancer

KW - PABC

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84889010615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889010615&partnerID=8YFLogxK

U2 - 10.1038/onc.2013.521

DO - 10.1038/onc.2013.521

M3 - Article

C2 - 24317513

AN - SCOPUS:84889010615

VL - 33

SP - 5729

EP - 5739

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 50

ER -